SAHPRA proposals Nov 2009 A GLIMPSE OF WHAT SAHPRA IS INTENDED TO BECOME KEY PROPOSALS FOR SAHPRA NOVEMBER 2009 DR NICHOLAS CRISP.

Slides:



Advertisements
Similar presentations
Board Governance: A Key to Quality Organizations
Advertisements

Armand Racine Consultant Chemicals Branch
Organizational Governance
23 March 2011 Madeleine Pearce Chair: SAMED Regulatory Committee
Managing Risk: A Framework and Reporting Cycle 2014.
Auditing, Assurance and Governance in Local Government
Business Case for the Pongola to Umzimkulu CMA D: WMI Governance.
Audit Committee in Albania Legal framework Law 9226 /2006 “On banks in Republic of Albania” Law 9901/2008 “On entrepreneurs and commercial companies” Corporate.
THE MEDICINES CONTROL COUNCIL (MCC) Presentation to the Portfolio Committee on Health 24 June 2008.
1 STRATEGIC HEALTH PLAN AND ANTICIPATED CHANGES TO MRA/MCC Dr Joey Gouws Director: Inspectorate and Law Enforcement Medicines Regulatory Authority (MRA)
Responsible Sponsorship A case study Dr Birgit Whitman, Head of Research Governance.
IS Audit Function Knowledge
Portfolio Committee on Health BRIEFING ON THE MEDICINES AND RELATED SUBSTANCES AMENDMENT BILL Date: 3 September 2014.
Regulatory Body MODIFIED Day 8 – Lecture 3.
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
ZHRC/HTI Financial Management Training
Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.
Financial Management for Africa Centers of Excellence Project Presented by Patrick Umah Tete, World Bank on May 20, 2014 during the launch of the project.
Delegation of Commissioning Responsibilities (DR) to pathfinders and emerging Clinical Commissioning Groups (CCGs) - What is it? Why should pathfinders.
DPE Shareholder Oversight & Risk Management
Briefing to the Health Portfolio Committee: Operational Activities and Budgets KP Matshidze Acting CEO and Registrar Council for Medical Schemes XX August.
New Zealand Medicines and Medical Devices Safety Authority A business unit of the Ministry of Health.
SRA Enabling Programme SRA Board Meeting – Public Session Carey Street, London 26 th February 2009.
Presentation on the Medicines and Related Substances Amendment Bill (Bill 6B of 2014) Select Committee on Social Services 25 August 2015.
Perspectives on Maximising Accountability Andy Wynne.
CCAB Training Providers Event 17 November 2008 Reviews Required by QAC Heather Briers Director Chartered Accountants Regulatory Board.
REPORT ON THE MINISTERIAL TASK TEAM REVIEW OF MEDICINES CONTROL COUNCIL AND RECOMMENDATIONS ON THE NEW REGULATORY AUTHORITY PRESENTATION TO HEALTH PORTFOLIO.
SALDA Presentation to the Honourable Portfolio Committee on Health National Health Act Amendment Bill B March 2012.
Information for New Members of Crown Entity Boards Crown copyright: State Services Commission, February
SOUTH AFRICAN DIAMOND AND PRECIOUS METALS REGULATOR (SADPMR)
Name Position Organisation Date. What is data integration? Dataset A Dataset B Integrated dataset Education data + EMPLOYMENT data = understanding education.
November 29, The Implementation of the 8th Directive Public Oversight in Hungary Katalin Fekete Vice President Hungarian Chamber of Auditors.
CIVILIAN SECRETARIAT FOR POLICE STATUS REPORT ON IMPLEMENTATION OF THE CIVILIAN SECRETARIAT FOR POLICE SERVICE ACT 2 OF 2011 PORTFOLIO COMMITTEE ON POLICE.
Cape Town 1 June Compensation Fund Overview Achievements Challenges Key Priorities 2004/5 Statistics Budget.
REPORTING STRUCTURES FOR SASSA PFMA / SASSA ACT / FLOW OF FUNDS Presenter: Brenton Van Vrede | Director, National Treasury | 20 June 2010.
1 FEEDBACK ON MCC PROJECT MEETING HELD ON 14 MAY 2010 Dr Dorcas Peta 4 JUNE 2010.
Crown copyright: State Services Commission, March Information for New Members of Crown Entity Boards Information for New Members of Crown Entity.
IPASA presentation to Portfolio Committee on Health 31 October 2014 Abeda Williams.
Staffing and training. Objectives To understand approaches to the development of strategies and policies for staffing of a Regulatory Authority including.
TOURISM BILL “ THE CONTENTS ” Friday; 17 May 2013.
PUBLIC–PRIVATE PARTNERSHIP (PPP) FRAMEWORK AND GUIDELINES Syed M. Ali Zaidi, P.Eng. PM(Stanford), Ph.D. Director, Strategic Partnerships Alberta Infrastructure.
Tax Administration Diagnostic Assessment Tool MODULE 11 “POA 9: ACCOUNTABILITY AND TRANSPARENCY”
4rd Meeting of the Steering Committee on Competence of Human Resources for Regulatory Bodies Vienna, 4-7 December 2012 Current Status of the Human Resources.
Presentation to the Portfolio Committee Establishment of an Agency for Social Security 26 February 2003 Department of Social Development.
Communication of the Strategic and Annual Audit Plan (Dutch situation)
PRESENTATION TO THE PORTFOLIO COMMITTEE ON COMMUNICATIONS ON NEMISA’S ANNUAL REPORT FOR 2012/ OCTOBER
Audit Committee in the Public Sector 30 September 2015 Corporate Executives: Barry Wheeler.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
The First Conference for Medicines Regulatory Authorities In Sudan and Neighboring Countries Khartoum December 2014 Alain PRAT, Technical Officer,
The Strategic Responsibilities of Governing Bodies Andrew Wilkinson Chair, Board of Governors, University of Wales, Newport and Chair of Chairs of Higher.
The International Society for Quality in Health Care (ISQua) – Guidelines.
Incorporating Privacy Into Systems Development Methodology Phil Moleski Director Corporate Information Technology Branch Saskatchewan Health
LEGISLATIVE FRAMEWORK AND M&E PROCESS
Governance and Management Trust Board of Directors Trustees for all Academies in Trust Senior Management Staff Appointed by Board to discharge.
BREEDE-GOURITZ ANNUAL PERFORMANCE PLAN & STRATEGIC PLAN
Governance and Management
Industry meeting with Nicholas Crisp on 27 February 2012
IIASA Governance Review
Medicines Control Council (MCC) &
Presentation to the Parliamentary Portfolio Committee on Energy
Money Bills Amendment Procedure and Related Matters Bill [B 75–2008]
Portfolio Committee Presentation 7 March 2007
Corporate Governance It is a system by which companies are managed and directed in the best interests of the owners and shareholders. It refers to the.
1/12/2019 Amendment Bill 6D of 2014 Briefing to the Portfolio Committee of Health 04 November 2015.
Transparency … and Accountability May 2011
Medicines Control Council (MCC) &
Increasing and Demonstrating value and of Internal Audit
Stakeholder Engagement: Webinar Part I: The Regulatory Development Process for the Government of Canada Part II: Making Technical Regulations Under.
COMMUNITY SCHEMES OMBUD SERVICE – PROGRESS REPORT
Portfolio Committee on Communications
Presentation transcript:

SAHPRA proposals Nov 2009 A GLIMPSE OF WHAT SAHPRA IS INTENDED TO BECOME KEY PROPOSALS FOR SAHPRA NOVEMBER 2009 DR NICHOLAS CRISP

The Challenge SAHPRA proposals Nov 2009

Backlog Project Sept to Nov 2009 Total 53 people to augment and assist MRA – Clerks – Technical Specialists – Evaluators – IT support – Inspectors – Managers and Deputy Registrar Audit the applications Address outstanding paperwork Industry confirmation of audit SAHPRA proposals Nov 2009

Backlog Project (cont) Accelerate evaluation and approval process Accelerate the EDMS implementation Secure back-ups and prepare disaster recovery Inspection of wholesalers Improve flow of documents Cautiously optimistic about the improvements But how to prevent a repeat and build a sound future..... SAHPRA proposals Nov 2009

Starting Point - MCC’s mandate Registration of medicines (human and animal) based on quality, safety and efficacy Control of medical devices (covered in the Act but not provided for in regulations) Approval and monitoring of clinical trials Monitoring of safety Response to signals Licensing of manufacturers, wholesalers and distributors

and MCC’s obligations Ensuring public safety Ensuring public protection Ensuring transparency in its processes Accountability to the public, the clients (industry and providers) and the public Responsiveness to the environment Risk assessment i.e. minimisation of harm and maximization of benefit SAHPRA proposals Nov 2009

Present MCC Council Committees Supported by MRA SAHPRA proposals Nov 2009

Cluster: Pharmaceutical and Related Product Regulation & Management Registrar MRA SAHPRA proposals Nov 2009

Proposed Future Independent public entity (Schedule 3 PFMA) – Board appointed by Minister and authority assigned by Minister – Committees of Board (Governance) – CEO and Executives appointed by Board – Councils (Technical Committees) Own buildings, IT, personnel and other systems Own revenue generation, retention and management – Minister of Health and Treasury approve tariffs SAHPRA proposals Nov 2009

Possible Structure Single Board of Management Twin Regulatory Councils (and Committees) – RCM (Regulatory Council for Medicines) 9 Standing Committees – RCMDD (Regulatory Council for Medical Devices and Diagnostics) 3 Standing Committees SAHPRA proposals Nov 2009

Macro Organisation SAHPRA Organorgam v xlsx SAHPRA Organorgam v xlsx BOARD PURPOSE: To set policy and standards for the registration and ongoing monitoring of health products within the context of a National Drug Policy and the National Health Policy Framework and to ensure good governance of the Agency and that it performs its statutory mandate to the highest levels of ethics and technical quality BOARD FUNCTIONS: 1. To provide oversight over the Authority, and in particular ensure – (a) the good governance of- and financial oversight over the Authority; (b) that the Authority performs its statutory mandate to the highest levels of ethics and technical quality; (c) alignment with National Health Policy; (d) the strategic placement of the Authority within the South African Development Community and the African continent 2. To prepare an annual strategic plan, linked to an annual budget to be reviewed and approved by the Ministry of Health (also quarterly reporting to the Minister of Health) 3. To publish quarterly performance reports for stakeholders and the general public SAHPRA proposals Nov 2009

Small Board, Councils, Committees SAHPRA Board (7 non-Exec, 2 Exec)(4 meetings pa) RCM (10 experts)(6 meetings pa) – Committees max 5 perm plus ad hoc (6 meetings pa) RCMDD (6 experts) (6 meetings pa) – Committees max 5 perm plus ad hoc (6 meetings pa) Councils decisions on registration – Minister Appeals Committees - Final SAHPRA proposals Nov 2009

Organisational improvement Reception – Electronic registration – Electronic document tracking – Project Managers – Complaints Centre Types of Assessment – All 3 types (according to policy) medicines – Move devices and in-vitro diagnostics SAHPRA proposals Nov 2009

Other Features More permanent Evaluators and Assessors Principle of payment upon service Increased fees Shorten TAT Fair queuing Tracking progress Communication with industry & other role-players SAHPRA proposals Nov 2009

Early days - Process SAHPRA - consultation and documents (after Minister authorises) Technical Task Team consultation and previous Ministerial report Needs a Project Plan – What will it look like? – What will it cost? – Can it generate its own funds? – Seed capital from where? – Personnel remuneration system, skills and numbers? – IT solutions? – Legal requirements? – Where should it be located? – Document management? SAHPRA proposals Nov 2009

More process Timeframes?? Consultation process – Internal – External Statutory process Budget cycle and financial compliance etc We have a long way to go ………….. SAHPRA proposals Nov 2009

Questions

SAHPRA proposals Nov 2009